214 related articles for article (PubMed ID: 29801401)
1. Study Protocol: Prospective Study of Concurrent Chemoradiotherapy with S-1 and Hypofractionated Radiotherapy for Outpatients with Early Glottic Squamous Cell Carcinomas.
Kimura K; Itoh Y; Okada T; Kubota S; Kawamura M; Nakahara R; Oie Y; Kozai Y; Takase Y; Tsuzuki H; Nishio N; Hiramatsu M; Fujimoto Y; Mizutani T; Hirakawa A; Naganawa S
Asian Pac J Cancer Prev; 2018 May; 19(5):1195-1199. PubMed ID: 29801401
[TBL] [Abstract][Full Text] [Related]
2. Critical evaluation of a prospective study of concurrent chemoradiotherapy with S-1 for early glottic carcinoma.
Kimura K; Itoh Y; Okada T; Nakahara R; Kawamura M; Kubota S; Itoh J; Hiramatsu M; Fujimoto Y; Shibata T; Naganawa S
Anticancer Res; 2015 Apr; 35(4):2385-90. PubMed ID: 25862904
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of concurrent chemoradiotherapy with S-1 in patients with stage II (T2N0M0) squamous cell carcinoma of the Pharynx or Larynx.
Taguchi T; Takahashi M; Nishimura G; Shiono O; Komatsu M; Sano D; Sakuma Y; Tanigaki Y; Kubota A; Taguri M; Hata M; Oridate N
Jpn J Clin Oncol; 2014 Dec; 44(12):1158-63. PubMed ID: 25267992
[TBL] [Abstract][Full Text] [Related]
4. [Concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma].
Ikeda Y; Tsukuda M; Tanigaki Y; Yabuki K; Mitake D; Ishitoya J
Gan To Kagaku Ryoho; 2008 May; 35(5):789-92. PubMed ID: 18487914
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II trial of concurrent use of S-1 and radiation therapy for T2 glottic cancer.
Nakayama M; Hayakawa K; Okamoto M; Niibe Y; Ishiyama H; Kotani S
Jpn J Clin Oncol; 2010 Oct; 40(10):921-6. PubMed ID: 20495190
[TBL] [Abstract][Full Text] [Related]
6. Optimized treatment strategy of radiotherapy for early glottic squamous cell carcinomas: An initial analysis.
Kimura K; Itoh Y; Okada T; Kubota S; Kawamura M; Nakahara R; Oie Y; Kozai Y; Takase Y; Tsuzuki H; Nishio N; Hiramatsu M; Fujimoto Y; Mizutani T; Naganawa S
Nagoya J Med Sci; 2017 Aug; 79(3):331-338. PubMed ID: 28878438
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy concurrent with S-1 and radiotherapy alone for T2N0 glottic carcinoma: a retrospective comparative study.
Higashino M; Kawata R; Lee K; Nishikawa S; Ichihara S; Uesugi Y
Auris Nasus Larynx; 2014 Aug; 41(4):364-8. PubMed ID: 24656970
[TBL] [Abstract][Full Text] [Related]
8. Concurrent chemoradiotherapy with carboplatin and uracil-ftegafur in patients with stage two (T2 N0 M0) squamous cell carcinoma of the glottic larynx.
Taguchi T; Tsukuda M; Mikami Y; Horiuchi C; Ishitoya JI; Katori H
J Laryngol Otol; 2006 Jun; 120(6):478-81. PubMed ID: 16563197
[TBL] [Abstract][Full Text] [Related]
9. Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604).
Tahara M; Fuse N; Mizusawa J; Sato A; Nihei K; Kanato K; Kato K; Yamazaki K; Muro K; Takaishi H; Boku N; Ohtsu A
Cancer Sci; 2015 Oct; 106(10):1414-20. PubMed ID: 26250827
[TBL] [Abstract][Full Text] [Related]
10. Concurrent chemoradiotherapy with conventional fractionated radiotherapy and low-dose daily cisplatin plus weekly docetaxel for T2N0 glottic cancer.
Saitoh JI; Shirai K; Imaeda M; Musha A; Abe T; Shino M; Takayasu Y; Takahashi K; Chikamatsu K; Nakano T
Radiat Oncol; 2017 Feb; 12(1):39. PubMed ID: 28219396
[TBL] [Abstract][Full Text] [Related]
11. A phase I study of concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma.
Tsuji H; Kiba T; Nagata M; Inoue T; Yukawa H; Yamashita T; Shimode Y; Murata H; Nagata K; Tomoda K
Oncology; 2006; 71(5-6):369-73. PubMed ID: 17851262
[TBL] [Abstract][Full Text] [Related]
12. Concurrent chemoradiotherapy with S-1 for T2N0 glottic squamous cell carcinoma.
Nonoshita T; Shioyama Y; Nakamura K; Nakashima T; Ohga S; Yoshitake T; Ohnishi K; Terashima K; Asai K; Honda H
J Radiat Res; 2010; 51(4):481-4. PubMed ID: 20601829
[TBL] [Abstract][Full Text] [Related]
13. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis: concurrent chemoradiotherapy and adjuvant chemotherapy for T2N0 glottic squamous cell carcinoma.
Nonoshita T; Shioyama Y; Kunitake N; Nakamura K; Nomoto S; Ohga S; Toriya Y; Ono M; Honda H
Fukuoka Igaku Zasshi; 2009 Jan; 100(1):26-31. PubMed ID: 19378773
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx following concurrent chemoradiation therapy with cisplatin and 5-fluorouracil for laryngeal preservation.
Furusaka T; Susaki Y; Saito T; Katsura Y; Ikeda M
Acta Otolaryngol; 2013 Jan; 133(1):91-8. PubMed ID: 23106387
[TBL] [Abstract][Full Text] [Related]
16. A phase I study of concurrent chemoradiotherapy using oral s-1 for head and neck cancer.
Fujimoto Y; Kato S; Itoh Y; Naganawa S; Nakashima T
Anticancer Res; 2014 Jan; 34(1):209-13. PubMed ID: 24403464
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for local control in patients receiving radiation therapy for early glottic cancer: anterior commissure involvement and effect of chemoradiotherapy.
Kitani Y; Kubota A; Furukawa M; Sato K
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1011-7. PubMed ID: 25726168
[TBL] [Abstract][Full Text] [Related]
18. Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation.
Spector JG; Sessions DG; Chao KS; Haughey BH; Hanson JM; Simpson JR; Perez CA
Head Neck; 1999 Dec; 21(8):707-17. PubMed ID: 10562683
[TBL] [Abstract][Full Text] [Related]
19. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
[TBL] [Abstract][Full Text] [Related]
20. Early glottic cancer: the influence of primary treatment on voice preservation.
Lesnicar H; Smid L; Zakotnik B
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1025-32. PubMed ID: 8985023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
